Search hospitals > New York > New York
Weill Cornell Medical College
Claim this profileNew York, New York 10065
Global Leader in Lymphoma
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Acute Myeloid Leukemia
Conducts research for Prostate Cancer
Conducts research for Skin Cancer
1175 reported clinical trials
225 medical researchers
Summary
Weill Cornell Medical College is a medical facility located in New York, New York. This center is recognized for care of Lymphoma, T-Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, Prostate Cancer, Skin Cancer and other specialties. Weill Cornell Medical College is involved with conducting 1,175 clinical trials across 1,656 conditions. There are 225 research doctors associated with this hospital, such as Pashtoon Kasi, MS, Alexander J. Chou, Koen Van Besien, MD, and Scott Tagawa, MD.Area of expertise
1Lymphoma
Global LeaderStage IV
Stage II
Stage III
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderFLT3 positive
CD5 positive
Stage II
Top PIs
Pashtoon Kasi, MSUniversity of Iowa/Holden Comprehensive Cancer Center3 years of reported clinical research
Studies Colorectal Cancer
Studies Stomach Cancer
19 reported clinical trials
48 drugs studied
Alexander J. ChouNYP/Weill Cornell Medical Center7 years of reported clinical research
Expert in Uterine Tumors
Expert in Cancer
17 reported clinical trials
39 drugs studied
Koen Van Besien, MDWeill Cornell Medical College7 years of reported clinical research
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Lymphoma
15 reported clinical trials
23 drugs studied
Scott Tagawa, MDWeill Cornell Medical College4 years of reported clinical research
Expert in Prostate Cancer
Studies Renal Cell Carcinoma
14 reported clinical trials
32 drugs studied
Clinical Trials running at Weill Cornell Medical College
Prostate Cancer
Lymphoma
Breast Cancer
Myelofibrosis
Heart Failure
Multiple Myeloma
Lung Cancer
Brain Tumor
Colon Cancer
Colitis
Pembrolizumab + AR Inhibitors
for Prostate Cancer
This is a phase I/II study investigating the combination of 225Ac-J591 (a drug that can deliver radiation to prostate cancer cells) with pembrolizumab (immunotherapy, a drug that increases the immune system's ability to destroy cancer cells). This study will assess whether 225Ac-J591 + pembrolizumab + androgen receptor pathway inhibitor (ARPI) is more effective against prostate cancer than pembrolizumab + ARPI alone.
Recruiting2 awards Phase 1 & 29 criteria
Radium-223 + Docetaxel
for Prostate Cancer
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Recruiting2 awards Phase 323 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Weill Cornell Medical College?
Weill Cornell Medical College is a medical facility located in New York, New York. This center is recognized for care of Lymphoma, T-Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, Prostate Cancer, Skin Cancer and other specialties. Weill Cornell Medical College is involved with conducting 1,175 clinical trials across 1,656 conditions. There are 225 research doctors associated with this hospital, such as Pashtoon Kasi, MS, Alexander J. Chou, Koen Van Besien, MD, and Scott Tagawa, MD.
Where is Weill Cornell Medical College located?
**Directions to Weill Cornell Medical College Hospital, New York, NY:**
- **Subway:** Take the Q line to 72nd Street, then walk two blocks east to York Avenue.
- **Driving from the South:** Take the FDR Drive to the 61st Street exit, then make a right onto York Avenue.
- **Driving from the North:** Take the FDR Drive to the 71st Street exit, then make a left onto York Avenue.
Who should I call to ask about financial aid or insurance network?
**Weill Cornell Medical College Hospital Financial Assistance and Contact Information:**
- **Financial Aid Contact:** Office of Financial Aid and Student Planning Services, Phone: (646) 962-3479, Email: FinAid@med.cornell.edu. Director: Alicia Stewart (als2373@med.cornell.edu), Manager: LLeny De La Cruz (lld4002@med.cornell.edu). Address: 1300 York Avenue, Room C-114, New York, NY 10065.
- **Insurance Inquiries:** Refer to the Insurance Information page on the Student Services website.
- **General Inquiries:** Phone: (212) 746-6000, Contact form available on their website.
- **Billing Questions:** Email: WCMBilling@med.cornell.edu, Phone: (646) 962-5700.
What insurance does Weill Cornell Medical College accept?
Weill Cornell Medical College accepts a wide range of insurance plans, including Medicare and most major insurance plans available in New York. Accepted insurances include AETNA (HMO, Medicare, PPO), Empire Blue Cross/Blue Shield (EPO, HMO, Mediblue (Senior), PPO), Oxford Health Plans (Freedom, Liberty, Medicare Advantage), and United Health Care (Community Plan, Medicare), among others. It's important for patients to confirm the specific physician's participation in their plan and understand any required referrals or authorizations. Accepted payment methods for co-payments or non-covered services include cash, check, Mastercard, Visa, Discover, and American Express.
What awards or recognition has Weill Cornell Medical College received?
Weill Cornell Medical College in New York has been awarded a $49 million NIH-funded Clinical and Translational Science Award (CTSA) for its research efforts. The institution's researchers have received notable recognition, including Dr. Robert Schwartz's election to the American Society for Clinical Investigation (ASCI), Dr. Ria Goswami's Gilead Research Scholars Award, and Dr. Inmaculada de Melo-Martin's fellowship with the European Academy of Sciences.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.